CHAMPIONS ONCOLOGY, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
CHAMPIONS ONCOLOGY, INC. (CSBR) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $66.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-09-11
- 2026-07-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $66.00K.
- 2026-04-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $85.00K.
- 2026-01-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $105.00K.
- 2025-10-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $143.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed |
|---|---|---|
| 2026-07-31 | $66.00K 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $85.00K 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $105.00K 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $143.00K 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $182.00K 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $220.00K 10-K · filed 2026-07-27 | $1.00M 10-K · filed 2025-07-23 |
| 2025-01-31 | $258.00K 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $296.00K 10-Q · filed 2024-12-16 | |
| 2024-07-31 | $333.00K 10-Q · filed 2024-09-13 | |
| 2024-04-30 | $1.00M 10-K · filed 2025-07-23 | |
| 2023-04-30 | $1.00M 10-K · filed 2024-07-19 | |
| 2022-04-30 | $713.00K 10-K · filed 2023-07-24 | |
| 2022-01-31 | $0.00 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $0.00 10-Q · filed 2021-09-13 | |
| 2021-04-30 | $343.00K 10-K · filed 2022-07-22 | |
| 2021-01-31 | $0.00 10-Q · filed 2021-03-15 | |
| 2020-10-31 | $343.00K 10-Q · filed 2020-12-14 | |
| 2020-07-31 | $343.00K 10-Q · filed 2020-09-14 | |
| 2020-04-30 | $343.00K 10-K · filed 2021-07-26 | |
| 2020-01-31 | $343.00K 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $366.00K 10-Q · filed 2019-12-16 | |
| 2019-07-31 | $366.00K 10-Q · filed 2019-09-16 | |
| 2019-04-30 | $366.00K 10-K · filed 2020-07-28 | |
| 2019-02-01 | $0.00 10-Q · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |